Sign up
Quantellect · Congress · Trade Detail
NYSE: ABBVAbbVie Inc
RepublicanHouse

Kenny Marchant bought AbbVie Inc (NYSE: ABBV)

Kenny Marchant (R-TX), a U.S. Representative, has disclosed 13 trades in AbbVie Inc (ABBV) since 2015, 6 purchases and 7 sales, worth an estimated $528K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Kenny Marchant bought $1,001 - $15,000 of AbbVie Inc (NYSE: ABBV) on December 19, 2019. Since that trade, ABBV is up +286.67% against the S&P 500 up +149.97%, an outperformance of +136.70%.

Across these filings, Kenny Marchant has been a net seller of ABBV (a buy-to-sell ratio of 0.86). The most recent disclosed ABBV transaction shown was dated November 14, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABBV trades
13
Disclosed Vol
$528K
Buys
6
46%
Sells
7
54%
Buy / Sell
0.86
ratio
First → Last
2015–2020

Kenny Marchant's ABBV trades vs the price

ABBV is up +286.67% since Kenny Marchant bought on December 19, 2019, versus +149.97% for the S&P 500.

Performance since this trade

Price change since trade
+286.67%
S&P 500 change since trade
+149.97%
Outperformance vs S&P 500
+136.70%

All Kenny Marchant ABBV trades

TradedTypeSizeReturnEst. profit
November 14, 2020BUY$80.18+228.40%+$54K
November 12, 2020BUY$79.01+233.24%+$55K
December 19, 2019BUY$68.09+286.67%+$16K
November 23, 2016SELL$40.57+548.95%
November 23, 2016SELL$40.57+548.95%
November 22, 2016SELL$39.73+562.71%
May 14, 2015BUY$42.12+525.17%+$24K
May 11, 2015BUY$41.62+532.55%+$228K
May 11, 2015SELL$41.62+532.55%
May 11, 2015SELL$41.62+532.55%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Kenny Marchant & ABBV trading FAQ

Is it legal for Kenny Marchant to trade AbbVie Inc (ABBV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Kenny Marchant buy ABBV?

Kenny Marchant disclosed a purchase of $1,001 - $15,000 of AbbVie Inc (ABBV) on December 19, 2019, according to public STOCK Act filings.

How has ABBV performed since Kenny Marchant's trade?

Since Kenny Marchant bought ABBV on December 19, 2019, the stock is up +286.67%, versus +149.97% for the S&P 500 over the same period, an outperformance of +136.70%.

How many times has Kenny Marchant traded ABBV?

Kenny Marchant has disclosed 13 ABBV trades since 2015 (6 purchases and 7 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABBV trades?

Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.

Kenny Marchant's ABBV tradesAll congressional filings for AbbVie IncKenny Marchant's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.